Valuation: Virbac

Market Cap 2.74B 3.13B 2.52B 2.34B 4.44B 297B 4.51B 30.23B 11.76B 146B 11.74B 11.48B 506B P/E 2026 *
16.2x
P/E 2027 * 14.4x
Enterprise Value 2.86B 3.26B 2.63B 2.44B 4.63B 310B 4.71B 31.56B 12.28B 153B 12.25B 11.99B 528B EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.68x
Free-Float
49.03%
Yield 2026 *
0.54%
Yield 2027 * 0.63%
1 day+0.46%
1 week-1.80%
Current month-1.80%
1 month-6.04%
3 months-6.04%
6 months-9.05%
Current year-8.67%
1 week 325
Extreme 325
335
1 month 325
Extreme 325
354
Current year 325
Extreme 325
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 2025-08-31
Chief Executive Officer 50 2024-09-26
Chief Operating Officer 64 2021-12-31
Director TitleAgeSince
Chairman 61 2006-03-31
Director/Board Member 68 2010-07-27
Director/Board Member 65 2017-09-04
Date Insider Type Main position Quantity % Market Cap.
24-04-21Sell

Chief Executive Officer

1,688 0.0200%
24-04-21Sell

Chief Executive Officer

810 0.0096%
24-04-21Sell

Chief Executive Officer

140 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+0.46%-1.80%-1.66%+30.60% 3.11B
+1.15%+6.16%-51.42%-54.36% 31.62B
-1.95%+0.12%+70.28%+145.42% 12.55B
-4.51%+1.26%-16.75%+0.25% 3.82B
-0.86%+6.58%+56.51%+32.81% 2.05B
-0.17%+3.25%-27.80%+18.24% 1.66B
-2.96%+5.48%+10.77%+130.80% 1.38B
-1.63%+5.85%-20.23%-9.49% 1.07B
+1.26%+2.26%-3.07%-17.33% 950M
-3.32%+0.82%-16.39%-47.96% 951M
Average -1.08%+1.72%+0.02%+22.90% 5.92B
Weighted average by Cap. +0.15%+1.96%-12.99%+6.91%

Financials

2026 *2027 *
Net sales 1.55B 1.77B 1.43B 1.32B 2.51B 168B 2.55B 17.09B 6.65B 82.77B 6.63B 6.49B 286B 1.64B 1.87B 1.51B 1.4B 2.66B 178B 2.7B 18.12B 7.05B 87.75B 7.03B 6.88B 303B
Net income 167M 191M 154M 143M 271M 18.11B 275M 1.85B 718M 8.94B 717M 701M 30.9B 190M 217M 175M 162M 308M 20.63B 313M 2.1B 817M 10.18B 816M 798M 35.19B
Net Debt 121M 138M 112M 103M 196M 13.12B 199M 1.34B 520M 6.48B 519M 508M 22.38B 26.49M 30.27M 24.42M 22.63M 42.96M 2.87B 43.65M 293M 114M 1.42B 114M 111M 4.9B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
26-07-07 326.50 +0.46% 3,371
26-07-06 €325.00 -2.11% 2,652
26-07-03 €332.00 +0.15% 3,366
26-07-02 €331.50 +0.45% 6,240
26-07-01 €330.00 -0.75% 5,366
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
325.00EUR
Average target price
412.88EUR
Spread / Average Target
+27.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock